- Home
- IINN vs FGEN Comparison
IINN vs FGEN Comparison
Compare IINN & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- FGEN
- Stock Information
- Founded
- IINN 2018
- FGEN 1993
- Country
- IINN Israel
- FGEN United States
- Employees
- IINN N/A
- FGEN N/A
- Industry
- IINN Medical/Dental Instruments
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- IINN Health Care
- FGEN Health Care
- Exchange
- IINN Nasdaq
- FGEN Nasdaq
- Market Cap
- IINN 34.1M
- FGEN 38.4M
- IPO Year
- IINN 2021
- FGEN 2014
- Fundamental
- Price
- IINN $1.25
- FGEN $11.48
- Analyst Decision
- IINN Strong Buy
- FGEN Strong Buy
- Analyst Count
- IINN 1
- FGEN 2
- Target Price
- IINN $2.00
- FGEN $146.50
- AVG Volume (30 Days)
- IINN 1.5M
- FGEN 64.8K
- Earning Date
- IINN 09-19-2025
- FGEN 08-11-2025
- Dividend Yield
- IINN N/A
- FGEN N/A
- EPS Growth
- IINN N/A
- FGEN N/A
- EPS
- IINN N/A
- FGEN N/A
- Revenue
- IINN N/A
- FGEN $7,346,000.00
- Revenue This Year
- IINN N/A
- FGEN N/A
- Revenue Next Year
- IINN $2,050.00
- FGEN N/A
- P/E Ratio
- IINN N/A
- FGEN N/A
- Revenue Growth
- IINN N/A
- FGEN N/A
- 52 Week Low
- IINN $0.40
- FGEN $4.50
- 52 Week High
- IINN $1.65
- FGEN $21.94
- Technical
- Relative Strength Index (RSI)
- IINN 54.38
- FGEN 59.87
- Support Level
- IINN $1.11
- FGEN $10.65
- Resistance Level
- IINN $1.23
- FGEN $12.60
- Average True Range (ATR)
- IINN 0.08
- FGEN 0.82
- MACD
- IINN 0.00
- FGEN -0.06
- Stochastic Oscillator
- IINN 50.00
- FGEN 55.20
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.